Acri.LISA® bifocal intraocular lens (Carl Zeiss UK) versus AcrySof® IQ ReSTOR® multifocal intraocular lens

Not Applicable

Completed

• Conditions: Cataracts; Eye Diseases; Other cataract

• Registration Number: ISRCTN64155646
• Lead Sponsor: Moorfields Eye Hospital NHS Foundation Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-09-06
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 188

Inclusion Criteria

1. Patients undergoing sequential bilateral cataract surgery or refractive lens exchange
2. Patients that want to be spectacle independent
3. Male or female, aged 21 years and above

Exclusion Criteria

1. Any significant ocular co-morbidity (amblyopia, age-related macular degeneration [ARMD], glaucoma, etc) precluding post-operative visual acuity (VA) of 20/30 or better or poor zonular/capsular stability (e.g. after trauma/severe pseudoxanthoma elasticum [PXE])
2. Corneal astigmatism more than 1.50 D on IOLMaster keratometry. Corneal astigmatism between 1.00 - 1.50 D will be reduced using standardised limbal relaxing incisions (LRI).
3. IOLMaster biometry not possible
4. IOL power less than 10D or greater than 30D
5. Professional night drivers, pilots, and other occupations for which induced
dysphotopsia may be career threatening
6. Patients with severe psychiatric disorders
7. Vulnerable groups
8. Poor mobility
9. Poor comprehension of written English

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The presence of dysphotopsia symptoms (absent, mild, moderate, severe). Dysphotopsia<br>(glare/haloes/visual disturbances) will be assessed with a questionnaire. <br><br>Primary and secondary outcomes to be measured 4 - 6 months post-operatively.